Global Antidepressants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antidepressants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antidepressants report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidepressants market is projected to reach US$ 18090 million in 2034, increasing from US$ 14360 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antidepressants industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidepressants key manufacturers include H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson and Merck, etc. H Lundbeck, Astrazeneca, Eli Lilly and Company are top 3 players and held % sales share in total in 2022.
Antidepressants can be divided into Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors and Monoamine Oxidase Inhibitors, etc. Tricyclic Antidepressants is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidepressants is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Antidepressants industry development. In 2022, global % sales of Antidepressants went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidepressants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi
Segment by Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents
Hospitals
Clinics
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antidepressants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidepressants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidepressants industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidepressants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidepressants introduction, etc. Antidepressants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidepressants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Antidepressants industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidepressants key manufacturers include H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson and Merck, etc. H Lundbeck, Astrazeneca, Eli Lilly and Company are top 3 players and held % sales share in total in 2022.
Antidepressants can be divided into Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors and Monoamine Oxidase Inhibitors, etc. Tricyclic Antidepressants is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidepressants is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Antidepressants industry development. In 2022, global % sales of Antidepressants went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidepressants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi
Segment by Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents
Segment by Application
Hospitals
Clinics
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antidepressants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidepressants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidepressants industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidepressants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidepressants introduction, etc. Antidepressants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidepressants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
